Hemillan, Josephine M.
HRN: 19-37-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2024
CEFUROXIME 1.5GM (VIAL)
03/16/2024
03/16/2024
IV
1.5
Once
For TAHBSO
Waiting Final Action
03/18/2024
CEFUROXIME 500MG (TAB)
03/18/2024
03/24/2024
IV
500mg
BID
Sp Hysterctomy
Waiting Final Action